Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest

Bone Marrow Transplantation volume 33, pages 661–665 (2004)Cite this article

Summary:

This article describes the first case of acute myeloid leukemia (AML) in a healthy donor at 14 months after granulocyte colony-stimulating factor (G-CSF)-primed peripheral blood stem cell (PBSC) harvest. In September 2001, a healthy 61-year-old female was given G-CSF prior to PBSC harvest for her brother with multiple myeloma. In spite of successful engraftment, the recipient died from a disease relapse. In November 2002, the donor, admitted with high fever and leukocytosis with 98.5% blastoid cells, was diagnosed as having AML (M1). Her leukemia cells were positive for CD13, CD33, and G-CSF receptor without chromosomal abnormality and responded to G-CSF in vitro. During chemotherapy, she died of progressive pneumonia. If our case is truly the first, the incidence of leukemia in donors may not be higher than that of naturally occurring leukemia. However, efforts towards an international long-term study, or at least to report every case similar to ours, would be required to be conclusive.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Champlin RE, Schmitz N, Horowitz MM et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 2000; 95: 3702–3709.

    CAS  PubMed  Google Scholar 

  2. Gutierrez-Delgado F, Bensinger W . Safety of granulocyte colony-stimulating factor in normal donors. Curr Opin Hematol 2001; 8: 155–160.

    Article  CAS  PubMed  Google Scholar 

  3. Hasenclever D, Sextro M . Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks. Bone Marrow Transplant 1996; 17: S28–S30.

    PubMed  Google Scholar 

  4. Bergmann L, Maurer U, Weidmann E . Wilms tumor gene expression in acute myeloid leukemias. Leuk Lymphoma 1997; 25: 435–443.

    Article  CAS  PubMed  Google Scholar 

  5. Fukunaga R, Seto Y, Mizushima S, Nagata S . 3 different messenger-Rnas encoding human granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci USA 1990; 87: 8702–8706.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Shinjo K, Takeshita A, Ohnishi K, Ohno R . Granulocyte colony-stimulating factor receptor at various differentiation stages of normal and leukemic hematopoietic cells. Leuk Lymphoma 1997; 25: 37–46.

    Article  CAS  PubMed  Google Scholar 

  7. Kuwaki T, Hosoi T, Hanazono Y et al . Distribution of human granulocyte colony-stimulating factor receptors on hematopoietic and nonhematopoietic tumor cell lines. Jpn J Cancer Res 1990; 81: 560–563.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hino M, Suzuki K, Yamane T et al. Ex vivo expansion of mature human neutrophils with normal functions from purified peripheral blood CD34+ haematopoietic progenitor cells. Br J Haematol 2000; 109: 314–321.

    Article  CAS  PubMed  Google Scholar 

  9. Heil G, Barge AJ . Use of filgrastim (r-metHuG-CSF) in acute myeloid leukemia. In: Morstyn G, Dexter TM, Foote M (eds). Filgrastim (r-metHuG-CSF) in Clinical Practice, 2nd edn. Marcel Dekker, Inc.: New York, 1998, pp 511–531.

    Google Scholar 

  10. Negrin RS, Green PL . Filgrastim (r-metHuG-CSF) for the treatment of myelodysplastic syndrome. In: Morstyn G, Dexter TM, Foote M (eds) . Filgrastim (r-metHuG-CSF) in Clinical Practice. Marcel Dekker, Inc.: New York, 2nd edn. 1998, pp 491–509.

    Google Scholar 

  11. Cavallaro AM, Lilleby K, Majolino I et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2000; 25: 85–89.

    Article  CAS  PubMed  Google Scholar 

  12. Storek J, Dawson MA, Maloney DG . Normal T, B, and NK cell counts in healthy donors at 1 year after blood stem cell harvesting. Blood 2000; 95: 2993–2994.

    CAS  PubMed  Google Scholar 

  13. Anderlini P, Chan FA, Champlin RE et al. Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development. Bone Marrow Transplant 2002; 30: 661–663.

    Article  CAS  PubMed  Google Scholar 

  14. Sakamaki S, Matsunaga T, Hirayama Y et al. Hematological study of healthy-volunteers 5 years after G-CSF. Lancet 1995; 346: 1432–1433.

    Article  CAS  PubMed  Google Scholar 

  15. Stroncek DF, Clay ME, Herr G et al. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection. Transfusion 1997; 37: 304–308.

    Article  CAS  PubMed  Google Scholar 

  16. Gratwohl A, Passweg J, Baldomero H, Hermans J . Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1998; 22: 227–240.

    Article  CAS  PubMed  Google Scholar 

  17. Gratwohl A, Passweg J, Baldomero H, Hermans J . Blood and marrow transplantation activity in Europe 1997. Bone Marrow Transplant 1999; 24: 231–245.

    Article  CAS  PubMed  Google Scholar 

  18. Gratwohl A, Passweg J, Baldomero H et al. Hematopoietic stem cell transplantation in Europe 1998. Hematol J 2000; 1: 333–350.

    Article  CAS  PubMed  Google Scholar 

  19. Gratwohl A, Passweg J, Baldomero H, Urbano-Ispizua A . Hematopoietic stem cell transplantation activity in Europe 1999. Bone Marrow Transplant 2001; 27: 899–916.

    Article  CAS  PubMed  Google Scholar 

  20. Gratwohl A, Baldomero H, Passweg J, Urbano-Ispizua A . Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey. Bone Marrow Transplant 2002; 30: 813–831.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Fuchu Hospital, Osaka, Japan

    K Makita, A Mugitani, K Hagihara & T Ohta

  2. Clinical Hematology and Clinical Diagnostics, Osaka City University, Graduate School of Medicine, Osaka, Japan

    K Makita, K Ohta, K Hagihara, T Yamane & M Hino

Authors
  1. K Makita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Ohta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Mugitani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Hagihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Ohta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Yamane
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Hino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Hino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Makita, K., Ohta, K., Mugitani, A. et al. Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest. Bone Marrow Transplant 33, 661–665 (2004). https://doi.org/10.1038/sj.bmt.1704394

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704394

Keywords

This article is cited by

Search

Advanced search

Quick links